IDEX Work in process increased by 21.0% to $57.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.4%, from $44.60M to $57.70M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 10.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.97M | $41.59M | $47.40M | $53.00M | $54.10M | $49.90M | $54.30M | $54.90M | $50.50M | $47.00M | $44.50M | $37.70M | $40.40M | $43.80M | $34.40M | $44.60M | $51.40M | $52.60M | $47.70M | $57.70M |
| QoQ Change | — | -0.9% | +14.0% | +11.8% | +2.1% | -7.8% | +8.8% | +1.1% | -8.0% | -6.9% | -5.3% | -15.3% | +7.2% | +8.4% | -21.5% | +29.7% | +15.2% | +2.3% | -9.3% | +21.0% |
| YoY Change | — | — | — | — | +28.9% | +20.0% | +14.6% | +3.6% | -6.7% | -5.8% | -18.0% | -31.3% | -20.0% | -6.8% | -22.7% | +18.3% | +27.2% | +20.1% | +38.7% | +29.4% |
| % of Inventories | 11.7% | 11.7% | 12.8% | 12.4% | 11.8% | 11.0% | 11.5% | 11.0% | 10.5% | 10.5% | 10.6% | 8.8% | 9.4% | 9.0% | 8.0% | 9.6% | 10.5% | 10.6% | 9.9% | 11.5% |
| Share Change | — | +0.1pp | +1.0pp | -0.4pp | -0.5pp | -0.9pp | +0.6pp | -0.5pp | -0.6pp | +0.1pp | +0.1pp | -1.7pp | +0.6pp | -0.5pp | -1.0pp | +1.6pp | +1.0pp | +0.1pp | -0.7pp | +1.6pp |